Practice question

Answer the question and get instant feedback.

MediumCardiologyHeart failure therapy optimisationukmlamrcp part 1mrcgp aktpane

A 58-year-old man with heart failure (EF 30%) remains symptomatic (NYHA II) on ACE inhibitor and beta-blocker. K+ 4.6 mmol/L, eGFR 68. Next disease-modifying therapy?

Educational content. Not a substitute for clinical judgement or local policy.